Abbott Laboratories has agreed to a $670 million settlement to resolve lawsuits claiming its specialized infant formulas caused a dangerous intestinal disease in preterm babies.

The Department of Justice is shifting its prosecutorial strategy to balance corporate accountability with American enterprise, introducing new guidelines for self-disclosure and monitor duration.